The Dresden Symposium on Autoantibodies reaffirmed its role as a landmark event, bringing together world-renowned experts to discuss the latest advances in autoimmunity. The symposium provided an invaluable opportunity to explore new perspectives on autoimmune diseases, emerging biomarkers, and technological innovations that are shaping the future of diagnostics and patient care. Medipan & GA Generic […]

Anti-neutrophil cytoplasmic antibodies (ANCA) Anti-neutrophil cytoplasmic antibodies (ANCA) are key biomarkers in the diagnosis of ANCA-associated vasculitis (AAV), a group of rare but potentially life-threatening autoimmune diseases. They can also have clinical and diagnostic value in certain non-AAV conditions. Early and accurate detection of ANCA is critical for initiating treatment promptly and improving long-term outcomes. […]

09 – 12, September 2025 | Dresden Fair | Dresden, Germany Medipan & GA at DSA 2025 – Leading Autoantibody Diagnostics Introduction to DSA 2025 We are pleased to announce that Medipan & GA Generic Assays will once again take part in the 17th Dresden Symposium on Autoantibodies (DSA) 2025. The symposium is one of […]

We are pleased to share the results of a newly published peer-reviewed study in Scientific Reports that demonstrates the diagnostic performance of the CytoBead® ANA 2 assay1. In clinical diagnostics, the detection of antinuclear antibodies (ANA) is crucial in identifying systemic autoimmune rheumatic diseases (SARDs). Traditional diagnostics use a two-step process. First, ANA screening by […]

Type 1 diabetes management has long relied on insulin injections, carbohydrate counting, and vigilant blood sugar monitoring. But how will the landscape in the near future look like? According to prominent German pediatric endocrinologist Felix Reschke (Kinder- und Jugendkrankenhaus in Hannover), the next five years could redefine treatment strategies entirely – he said in an […]

June is recognized as Scleroderma Awareness Month to honor those affected by the disease. The month ends with World Scleroderma Day on June 29. This date commemorates Swiss painter Paul Klee, who died of systemic sclerosis in 19401. Scleroderma, or systemic sclerosis, is a rare autoimmune disease. It causes hardening and tightening of the skin […]

From September 9 to 12, 2025, the 17th Dresden Symposium on Autoantibodies will take place in Dresden, Germany. This year’s theme, “The Autoantibody Spectrum: Bridging Health, Diagnostics, and Disease,” brings together global experts for a deep dive into the evolving science of autoimmune diagnostics. The event also honors the legacy of Prof. Eng M. Tan, […]

Running together. Growing together. On May 21, 2025, Berlin once again turned into a vibrant sports capital as more than 20,000 enthusiastic runners took part in the IKK BB Berlin Company Run 2025. In the middle of this impressive event stood Team MEGA, represented by 17 motivated runners who proudly completed the 5.5-kilometer course. With […]

Celiac disease (CD) diagnosis has advanced significantly over the past decade. Global guidelines now emphasize a combination of serology, genetics, and histology. While regional approaches differ, all aim for accurate diagnosis with minimal invasiveness. Core serological markers include antibodies against tissue transglutaminase (tTG), deamidated gliadin peptide (DG), and endomysial antibodies (EmA), assessed in both IgA […]

Das Antiphospholipid-Syndrom (APS) ist ein bedeutender Risikofaktor für Schwangerschaftskomplikationen, doch seine Diagnose bleibt eine Herausforderung. Jüngste Fortschritte in der APS-Diagnostik liefern tiefere Einblicke in seine Rolle bei wiederholtem Schwangerschaftsverlust und Präeklampsie. Durch innovative Biomarkerforschung und verfeinerte Testmethoden wird die Diagnosesicherheit verbessert, sodass Risikopatientinnen präziser identifiziert und gezielt behandelt werden können. Erfahren Sie mehr über die neuesten Entwicklungen in der APS-Diagnostik und deren Auswirkungen auf die mütterliche und fetale Gesundheit.